- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Medical Devices
Lilly's $30.6M tax abatement request clears hurdle
April 18, 2013
IBJ StaffThe pharmaceutical firm has $400 million in projects in the works for its facilities south of downtown. City officials have
advanced its request for tax breaks to a public hearing and final consideration May 1.
MoreLilly seeks $30.6M in tax breaks on downtown projects
April 15, 2013
Mason KingIndianapolis development officials on Wednesday will weigh the 10-year requests from the pharmaceuticals giant related to
a new manufacturing plant and improvements to existing operations downtown.
MoreLilly to spend $180M doubling size of Indy plant
April 2, 2013
The new investment will bring the plant's total price tag to $320 million as the pharmaceutical giant seeks to increase production
of insulin and related products.
MoreMedical device maker moving to Noblesville, adding jobs
March 12, 2013
Fishers-based Nexxt Spine LLC, a manufacturer of spinal implants, is consolidating operations and moving its headquarters
and manufacturing facility to Noblesville.
MoreZimmer highly exposed to health-reform risk
January 28, 2013
J.K. WallShares of Zimmer Holdings Inc. have generated impressive returns of 23 percent in the past year and some 2013 product launches
could juice those results even further. But the Warsaw-based maker of orthopedic implants is also the most-exposed company
in its industry to two key elements of health care reform: the medical device tax and bundled payments.
MoreCook wins approval for new stent
November 19, 2012
J.K. WallBloomington-based Cook Medical won approval for the first drug-coated stent for clogged leg arteries in the United States,
which accounts for 40 percent of the soon-to-be $3 billion market.
MorePurdue researcher harbors high hopes for new venture
November 3, 2012
Scott OlsonPete Kissinger hopes Phlebotics will follow in the footsteps of another of his creations, Bioanalytical Systems Inc.
MoreLilly to spend $140M on new insulin cartridge plant
November 1, 2012
J.K. WallAbout 100 workers will staff the new plant, which will be constructed by spring 2014 and ready for operations in 2015. But
only “some” of that number will be new hires.
MoreOutlook gloomy for device investments
October 29, 2012
J.K. WallThe amount of venture capital invested in medical-device and equipment companies nationally has declined each quarter this
year, reaching levels not seen since 2004, according to data released Oct. 19 by the National Venture Capital Association
and PricewaterhouseCoopers.
MoreGrowing ENT market attracts Cook
September 10, 2012
J.K. WallBloomington-based Cook Medical announced a new division to capitalize on the growing market for minimally invasive procedures
to fix problems in ears, noses and throats, as well as other maladies of the head and neck.
MoreMedical startup plans 71 jobs, seeks incentives
June 21, 2012
The city of Indianapolis granted preliminary approval for an eight-year tax abatement to Arcamed Inc., which plans to purchase
$1.4 million in equipment to design and manufacture titanium and case-tray systems for surgical instruments.
MoreBiomet gives ortho industry hope
June 18, 2012
J.K. WallThe skies got a little brighter for the orthopedic industry on Friday after Warsaw-based Biomet Inc. reported strong quarterly
sales growth of 3.4 percent. That news sparked a small surge in the stock prices of two other Warsaw-based orthopedics companies.
MoreHouse swipes at health law with repeal of medical device tax
June 8, 2012
Republicans in the U.S. House joined with 37 Democrats to pass a bill repealing a medical-device tax, chipping away at the
2010 health-care law in a victory for companies including Indiana-based Zimmer Holdings Inc. and Boston Scientific Corp.
MoreFDA’s $6.4B drug review fee plan passes Senate
May 24, 2012
Bloomberg NewsThe U.S. Senate voted to let regulators collect on a $6.4 billion fee agreement struck with Indianapolis-based Eli Lilly and
Co., Medtronic Inc. and other companies to fund reviews of new drugs and medical devices through 2017.
MoreBioCrossroads has stoked state's life sciences industry, but challenges remain
February 11, 2012
J.K. WallIn the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies,
an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national
reports on life sciences.
MoreFrench breast-implant recall could sway U.S. device debate
January 19, 2012
Bloomberg NewsU.S. medical device makers have spent the last year urging government officials to approve high-risk products faster, like
their European counterparts. A scandal over leaking breast implants made in France, however, may make the argument more difficult.
MoreCity set to cancel tax abatement for medical device firm
January 18, 2012
Polymer Technology Systems said in 2007 that it would make a $3 million investment at its operation on Zionsville Road and
create 110 jobs.
MoreGlucose monitor deal helps Roche catch up
November 7, 2011
J.K. WallRoche Diagnostics will partner with a San Diego firm to incorporate its continuous glucose monitoring sensor with a wireless
handheld device Roche is developing to help diabetics test their blood sugar and track their glucose levels throughout the
day.
MoreOrtho firms pull back on doc payments
October 31, 2011
J.K. WallThe number of payments in excess of $1 million didn’t change substantially from year to year, but orthopedic companies
sharply cut their fees to surgeons who received the smallest amounts.
MoreCook Medical gets FDA panel's backing for stent
October 13, 2011
Bloomberg NewsThe device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery
of the upper leg.
MoreFDA: Cook Medical’s stent met efficacy, safety goals
October 11, 2011
Bloomberg NewsPeripheral vascular devices, including stents, angioplasty balloons and synthetic grafts, generated $4.3 billion in global
revenue last year and may earn $5.6 billion in 2014.
MoreIncentives flow to tech firm Positron, despite red ink
September 29, 2011
Chris O'MalleyThe molecular-imaging company is trying to transition its business model and get beyond a going-concern warning.
MoreGloomy outlook for medical device makers
September 12, 2011
J.K. WallThe next four years could be rough for makers of medical devices and orthopedic implants, including Bloomington-based Cook
Medical Inc. and Warsaw-based Zimmer Holding Inc. and Biomet Inc.—and not because of the 2010 health reform law.
MoreZimmer playing hardball with plaintiffs' lawyers
August 8, 2011
Bloomberg NewsThe Warsaw-based company has sued seven law firms this year and sent warning letters to at least three more, saying their
ads and Internet postings distorted the safety record of its $1.8 billion-a-year knee business.
MoreOrthopedics company plans $27M Indiana project
August 5, 2011
Associated PressWarsaw-based DePuy Orthopaedics expects to spend $20 million on manufacturing equipment and $7 million on research and development
equipment and have it installed before 2014.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Three Magi
Cats out of the bag. The object of the game is to get acquired. That means the company has no idea how to grow beyond a certain point. Email is a 1990s technology. I have laughed at this company since day one. Such a small bit player. If it was anywhere but here, it wouldn't be newsworthy.
Esther, Indy has passed Chicago in the local government corruption arena. Don't downgrade us. We're No. 1 in the Midwest.
Does the buyer get to keep the recent Accu-Chek J.D. Power award? Be careful, those Swiss cannot be trusted. Last June they pimped Mayor Ballard and former Governor Daniels at a media op, announcing plans to invest "$300 million at its Indianapolis headquarters, creating up to 100 new jobs by 2017," only to turn around and close the Roche Nutley, NJ facility and eliminate 1000 jobs there later the same week. It seems that healthcare can be innovated only as long as money is to be made. Right now Roche seems to have big eyes for China: there are many Chinese in China and potential billions in Swiss francs! Since Roche is having difficulty with US insurance companies swallowing the bill for overpriced cancer drugs (with debatable efficacy) why not sell insurance to the Chinese and market the drugs to them there? There is a name for these sort of business practices however proper decorum precludes it use in this forum.
Same kind of Luddites who oppose I-69. Guessing their 501(c)(4) application probably sailed right through the IRS.